The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines
The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines
复制标题
DOI：
10.1016/s0264-410x(03)00070-7
复制
发表时间：
2003-05-01
期刊：
影响因子：
5.5
通讯作者：
Nichol, KL
中科院分区：
文献类型：
--
作者：
Nichol, KL
流感是全球发病率和死亡率的主要原因。目前可用的灭活流感病毒疫苗是安全有效的预防流感。在所有年龄和风险群体中都可以看到大量的健康益处。评估接种疫苗经济效益的研究表明，接种疫苗具有很高的成本效益，在许多情况下可以节省老年人的费用。流感疫苗接种也与年轻人和儿童的显著经济效益有关。来自发展中国家和热带/亚热带地区的其他卫生经济学研究对于更好地了解流感的全球负担和疫苗接种的潜在益处至关重要。出版社：Elsevier Science Ltd
Influenza is a major cause of morbidity and mortality worldwide. Currently available inactivated influenza virus vaccines are safe and effective in preventing influenza. Substantial health benefits are seen across all age and risk groups. Studies assessing the economic benefits of vaccination suggest that vaccination is highly cost effective and in many cases cost saving among the elderly. Influenza vaccination has also been associated with significant economic benefits in younger adults and children. Additional health economic studies from developing countries and from tropical/subtropical regions will be vitally important for better understanding of the global burden of influenza and potential benefits of vaccination. Published by Elsevier Science Ltd.